NEW LONDON, Conn., Feb. 17 /PRNewswire-FirstCall/ -- The following statement is issued by Pfizer Inc to assist understanding of the company's position regarding a case that will be heard on February 22 before the U.S. Supreme Court (Kelo vs. City of New London and New London Development Corporation).
The headquarters of Pfizer Global Research & Development are in New London CT, but contrary to some recent reports:
- The role of Pfizer is not material to this case. Pfizer was never named
as a party to the lawsuit and the company has no stake in the outcome.
- Eminent domain played no part in the company's purchase of land in New
- Pfizer has no requirements for the proposed development and expects no
Pfizer is a good citizen and has delivered all its promises to the State and City. The corporation brought 1500 jobs to New London and is the city's largest single taxpayer. It is a major source of philanthropic and volunteer contributions. Pfizer has also delivered benefit by choosing to build on a derelict urban brown field, and investing in environmental remediation.
Photo: A free corporate logo to accompany this story is availableimmediately via Wieck Photo Database to any media with telephoto receiver orelectronic darkroom, PC or Macintosh, that can accept overhead transmissions.To retrieve a logo, please call 972-392-0888
CONTACT: Stephen Lederer, +1-860-732-9783, pager: 1-877-549-9848,email@example.com, or Liz Power, +1-860-732-4987,cell: +1-860-625-9360, firstname.lastname@example.org, both of Pfizer Inc